Aquis Stock Exchange Weekly Highlights 23/09/24

ProBiotix Health Plc announced a commercial partnership with Greek consumer brands specialist Eifron SA. Eifron will introduce YourBiotixBP tablets, containing LPLDL®, under its existing probiotic consumer brand, with the anticipated product launch expected in Q1 2025. Through this strategic partnership, Eifron will expand its own portfolio by including a product for lowering cholesterol and blood pressure based on LPLDL®. Read more

IntelliAM AI plc announced it has won contracts with Hovis for its consultancy reliability services. This includes contracts for 3 Hovis sites in East London, Nottingham and Glasgow, and project services for all Hovis manufacturing sites. The Company reports these service and project orders will be worth more than £100,000 over a 12-month period, starting October 2024. Read more

Valereum Plc announced the issuance of a Digital Asset Service Provider (DASP) licence for VLRM Markets S.A. DE C.V. in El Salvador. This enables VLRM Markets, acting as a regulated and licensed DASP, to establish and operate a real-world asset (RWA) ecosystem within El Salvador's progressive regulatory framework.

Andrew Hogg, Head of VLRM Markets Commented: “We are delighted to have been awarded this licence and we are looking forward to building our new business in El Salvador that will seek via its activities to bridge the gap between traditional assets and the digital world to capitalise on the burgeoning opportunity of the tokenisation of RWA.” Read more

Shortwave Life Sciences PLC reports that it has achieved a breakthrough in its journey to transform the treatment landscape of eating disorders. The Company announced positive safety results from its latest pre-clinical pharmacodynamics study, demonstrating the safety of its proprietary psilocybin-based drug combination at elevated doses. Read more

Equipmake Holdings PLC announced it has entered into a purchase order with Genco Energy Holdings Pty Ltd, the alliance company with New Zealand’s leading coach builder, Kiwi Bus Builders Ltd. Genco has signed an initial purchase order for four Zero Emission Drivetrains from Equipmake, which Kiwi Bus Builders will use to build trial zero-emission electric buses.

Ian Foley, CEO, said: “We are excited to collaborate with Genco and Kiwi Bus Builders on this pioneering project. This initial order for our Zero Emission Drivetrains highlights the critical role Equipmake can play in driving the shift towards cleaner, more sustainable mass transit solutions worldwide.” Read more

Oscillate Plc reported that the Company has now signed a conditional, binding Acquisition Agreement to acquire the entire issued share capital of Quantum Hydrogen Inc. which has exploration rights over approximately 60,000 acres in the State of Minnesota, USA. Additionally, the Company announced a £500,000 Placing by Peterhouse Capital. Read more